Cargando…

SARS-CoV-2 Virus-like Particles (VLPs) Specifically Detect Humoral Immune Reactions in an ELISA-Based Platform

A key in controlling the SARS-CoV-2 pandemic is the assessment of the immune status of the population. We explored the utility of SARS-CoV-2 virus-like particles (VLPs) as antigens to detect specific humoral immune reactions in an enzyme-linked immunosorbent assay (ELISA). For this purpose, SARS-CoV...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hirschberg, Stefan, Bauer, Hannes, Kamhieh-Milz, Julian, Ringel, Frauke, Harms, Christoph, Eddin, Omar Kamal, Pruß, Axel, Hanack, Katja, Schulze-Forster, Kai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9774516/ https://www.ncbi.nlm.nih.gov/pubmed/36546901 http://dx.doi.org/10.3390/antib11040076

Ejemplares similares

An Efficient and Scalable Method for the Production of Immunogenic SARS-CoV-2 Virus-like Particles (VLP) from a Mammalian Suspension Cell Line
por: Hirschberg, Stefan, et al.
Publicado: (2023)

SARS-CoV-2 neutralizing camelid heavy-chain-only antibodies as powerful tools for diagnostic and therapeutic applications
por: Schlör, Anja, et al.
Publicado: (2022)

Two RSV Platforms for G, F, or G+F Proteins VLPs
por: Ha, Binh, et al.
Publicado: (2020)

Oxidative Stress Is Predominant in Female but Not in Male Patients with Autoimmune Thrombocytopenia
por: Kamhieh-Milz, Julian, et al.
Publicado: (2014)

114 VLPs and particle vaccines
por: Buonaguro, Luigi
Publicado: (2014)

RNA: packaged and protected by VLPs
por: Fang, Po-Yu, et al.
Publicado: (2018)

Packaging of actin into Ebola virus VLPs
por: Han, Ziying, et al.
Publicado: (2005)

ELISA for detection of humoral immunity against measles
por: Zahoor, Muhammad Asif, et al.
Publicado: (2015)

Abrogation of contaminating RNA activity in HIV-1 Gag VLPs
por: Valley-Omar, Ziyaad, et al.
Publicado: (2011)

Exploring FeLV-Gag-Based VLPs as a New Vaccine Platform—Analysis of Production and Immunogenicity
por: Ortiz, Raquel, et al.
Publicado: (2023)

Functional RNAs: combined assembly and packaging in VLPs
por: Fang, Po-Yu, et al.
Publicado: (2017)

Structure-Based Design of Porcine Circovirus Type 2 Chimeric VLPs (cVLPs) Displays Foreign Peptides on the Capsid Surface
por: Wang, Dongliang, et al.
Publicado: (2018)

Interaction Between Virus-Like Particles (VLPs) and Pattern Recognition Receptors (PRRs) From Dendritic Cells (DCs): Toward Better Engineering of VLPs
por: Zepeda-Cervantes, Jesús, et al.
Publicado: (2020)

His-tag ELISA for the detection of humoral tumor-specific immunity
por: Goodell, Vivian, et al.
Publicado: (2008)

IL-17 in Peritoneal Dialysis-Associated Inflammation and Angiogenesis: Conclusions and Perspectives
por: Witowski, Janusz, et al.
Publicado: (2018)

The Role of Adipose Tissue in the Pathogenesis and Therapeutic Outcomes of Inflammatory Bowel Disease
por: Eder, Piotr, et al.
Publicado: (2019)

Differentially Expressed MicroRNAs in Maternal Plasma for the Noninvasive Prenatal Diagnosis of Down Syndrome (Trisomy 21)
por: Kamhieh-Milz, Julian, et al.
Publicado: (2014)

Production of Brazilian human norovirus VLPs and comparison of purification methods
por: Lamounier, Thais Alves da Costa, et al.
Publicado: (2015)

Construction of HER2-Specific HIV-1-Based VLPs
por: Martins, Sofia A., et al.
Publicado: (2022)

Zika virus-like particles (VLPs) produced in insect cells
por: de Mello, Renata Gois, et al.
Publicado: (2023)

Exploiting the Yeast L-A Viral Capsid for the In Vivo Assembly of Chimeric VLPs as Platform in Vaccine Development and Foreign Protein Expression
por: Powilleit, Frank, et al.
Publicado: (2007)

Developing a production process for influenza VLPs: a comparison between HEK 293SF and Sf9 production platforms
por: Thompson, Christine M, et al.
Publicado: (2013)

Diagnosis of Ocular Toxocariasis by Serum and Aqueous Humor IgG ELISA
por: Huang, Li, et al.
Publicado: (2021)

Dissolving Microneedles Loaded with Nanoparticle Formulation of Respiratory Syncytial Virus Fusion Protein Virus-like Particles (F-VLPs) Elicits Cellular and Humoral Immune Responses
por: Menon, Ipshita, et al.
Publicado: (2023)

Assembly of HCV E1 and E2 glycoproteins into coronavirus VLPs
por: Jourdan, N., et al.
Publicado: (2006)

Induction of Robust and Specific Humoral and Cellular Immune Responses by Bovine Viral Diarrhea Virus Virus-Like Particles (BVDV-VLPs) Engineered with Baculovirus Expression Vector System
por: Wang, Zhanhui, et al.
Publicado: (2021)

How to avoid pitfalls in antibody use
por: Pauly, Diana, et al.
Publicado: (2015)

MSC Therapies for COVID-19: Importance of Patient Coagulopathy, Thromboprophylaxis, Cell Product Quality and Mode of Delivery for Treatment Safety and Efficacy
por: Moll, Guido, et al.
Publicado: (2020)

Immunogenicity of Plant-Produced Human Papillomavirus (HPV) Virus-Like Particles (VLPs)
por: Naupu, Paulina N., et al.
Publicado: (2020)

A Comparative Study on Delivery of Externally Attached DNA by Papillomavirus VLPs and Pseudoviruses
por: Brendle, Sarah, et al.
Publicado: (2021)

224 Humoral immune response to COVID-19 vaccination in psoriasis patients on biologic therapy is impaired compared to healthy controls
por: Puschmann, H., et al.
Publicado: (2023)

Gene expression profile of peripheral blood mononuclear cells in response to HIV-VLPs stimulation
por: Buonaguro, Luigi, et al.
Publicado: (2008)

Scalable Production of HPV16 L1 Protein and VLPs from Tobacco Leaves
por: Zahin, Maryam, et al.
Publicado: (2016)

Establishment of Baculovirus-Expressed VLPs Induced Syncytial Formation Assay for Flavivirus Antiviral Screening
por: Dai, Shiyu, et al.
Publicado: (2018)

Interaction of Viral Capsid-Derived Virus-Like Particles (VLPs) with the Innate Immune System
por: Mohsen, Mona O., et al.
Publicado: (2018)

The Adoption of Viral Capsid-Derived Virus-Like Particles (VLPs) for Disease Prevention and Treatments
por: Bogani, Giorgio, et al.
Publicado: (2020)

Erythro-VLPs: Anchoring SARS-CoV-2 spike proteins in erythrocyte liposomes
por: Himbert, Sebastian, et al.
Publicado: (2022)

SARS-CoV-2 RBD dimers elicit response comparable to VLPs in mice
por: Love, J., et al.
Publicado: (2023)

HIV-1 sub-type C chimaeric VLPs boost cellular immune responses in mice
por: Pillay, Sirika, et al.
Publicado: (2010)

Intranasal Immunization with Influenza VLPs Incorporating Membrane-Anchored Flagellin Induces Strong Heterosubtypic Protection
por: Wang, Bao-Zhong, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_8ad33uealn5cvd9dncu4b3p8p5